Please login to the form below

Not currently logged in
Email:
Password:

Nabriva Therapeutics names Elyse Seltzer as CMO

She joins from GlaxoSmithKline

Clinical stage biopharma firm Nabriva Therapeutics has appointed Elyse Seltzer as chief medical officer.

The company is engaged on the research and development on novel anti-infective agents to treat serious infections, with a focus on the pleuromutilin class of antibiotics.

In her new role, Seltzer will supervise medical and regulatory aspects of clinical development and medical affairs, contributing to the company's clinical development strategy.

Commenting on her appointment, Seltzer said: “I am thrilled to join Nabriva. I am excited to have the opportunity to advance a novel class of antibacterials, particularly given the current and evolving challenges around resistance to currently available antibiotics. 

"I look forward to working with the highly experienced clinical team to fulfil this goal."

Seltzer joins Nabriva from GSK, where she was VP of global clinical sciences and operations. Prior to this, Seltzer was CMO at Tengion, a regenerative medicine company.

Dr Colin Broom, CEO of Nabriva, added: “We are very pleased to welcome Elyse to Nabriva. Her extensive experience in the anti-infective therapeutic area, and in leading international clinical development programs will enable us to efficiently advance our lead product, lefamulin, into late stage development for the treatment of CABP.”

Seltzer assumes the role from Dr William Prince, who will take up the position of senior VP of clinical science.

27th May 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics